Investor FAQs
Autolus Therapeutics plc
The Mediaworks
191 Wood Lane
White City
London
W12 7FP
United Kingdom & Maryland, USA
22 June 2018
$17.00
1 January to 31 December
Autolus Therapeutics’ American Depository Shares (ADS) are traded on the NASDAQ Global Select Market under the ticker symbol AUTL
Autolus Therapeutics does not anticipate declaring or paying dividends in the foreseeable future
With questions about Autolus Therapeutics’ ADSs, please contact Investor Relations at Autolus: [email protected]
Ernst & Young
Approximately 700
Please visit our About us, Technology, Pipeline and Careers sections for more information.
Please visit our news and SEC filings pages.
Please visit our SEC filings and Quarterly earnings pages.
Please visit our Investor relations section or email [email protected].